Rx — Prescription Required
ART Combination
3-MUNE
Bictegravir + Emtricitabine + Tenofovir Alafenamide 50/200/25mg
Manufacturer
Cipla Ltd
Pack Size
30 Tablets
Category
ART Combination
Prescription Status
Rx — Required
✓ Plain unmarked packaging
✓ No HIV branding on parcel
✓ Tamper-proof sealing
About 3-MUNE
3-MUNE is Cipla's single-tablet regimen combining Bictegravir (integrase inhibitor) with FTC+TAF NRTI backbone. Provides a high genetic barrier to resistance and excellent tolerability. Once daily, for India Only.
Dosage & Administration
One tablet once daily with or without food. No dose adjustment needed in mild-to-moderate renal impairment.
Dosage information is indicative only. Always follow the schedule prescribed by your physician.
Storage
Store below 30°C in a cool, dry place away from direct sunlight. Keep out of reach of children.
3-MUNE is a Schedule H drug. A valid prescription from a licensed medical practitioner is mandatory. This page is for informational purposes only and is not medical advice — consult your HIV physician before starting, changing, or stopping any antiretroviral therapy.
